
Incyclix Bio, a cell cycle control company, has announced the appointment of Kimberly Blackwell to its Board of Directors as …
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals

